DaVita (STU:TRL) Cyclically Adjusted Revenue per Share: €107.19 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:TRL DaVita Inc STU:TRL
82 GF Score
Price €203.00
GF Value €152.35
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita Cyclically Adjusted Revenue per Share?

DaVita STU:TRL -2.59% 82 Cyclically Adjusted Revenue per Share is €107.19 as of Mar. 2026. GuruFocus rates STU:TRL with a GF Score™ of 82/100 and a GF Value™ of €152.35 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

DaVita's adjusted revenue per share for the three months ended in Mar. 2026 was €42.896. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €107.19 for the trailing ten years ended in Mar. 2026.

During the past 12 months, DaVita's average Cyclically Adjusted Revenue Growth Rate was 15.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of DaVita was 24.40% per year. The lowest was 9.30% per year. And the median was 14.30% per year.

As of today (2026-08-04), DaVita's current stock price is €203.00. DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €107.19. DaVita's Cyclically Adjusted PS Ratio of today is 1.89.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DaVita was 1.95. The lowest was 0.78. And the median was 1.36.


DaVita  (STU:TRL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DaVita's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=203.00/107.19
=1.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DaVita was 1.95. The lowest was 0.78. And the median was 1.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


DaVita Cyclically Adjusted Revenue per Share Related Terms


DaVita Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for DaVita's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Cyclically Adjusted Revenue per Share Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.41 81.32 85.11 102.80 100.64

DaVita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.83 94.24 95.36 100.64 107.19

STU:TRL vs EHC, THC, ENSG: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PS Ratio falls into.


STU:TRL
82GF Score
DaVita Inc STU:TRL
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DaVita's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=42.896/330.2130*330.2130
=42.896

Current CPI (Mar. 2026) = 330.2130.

DaVita Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 15.904 241.018 21.790
201609 16.061 241.428 21.967
201612 13.007 241.432 17.790
201703 12.598 243.801 17.063
201706 12.385 244.955 16.696
201709 12.120 246.819 16.215
201712 12.714 246.524 17.030
201803 12.709 249.554 16.817
201806 14.194 251.989 18.600
201809 14.589 252.439 19.084
201812 14.901 251.233 19.585
201903 14.556 254.202 18.909
201906 15.083 256.143 19.445
201909 17.429 256.759 22.415
201912 20.015 256.974 25.719
202003 20.263 258.115 25.923
202006 20.613 257.797 26.403
202009 20.028 260.280 25.409
202012 20.639 260.474 26.165
202103 20.806 264.877 25.938
202106 21.725 271.696 26.404
202109 22.739 274.310 27.373
202112 24.862 278.802 29.447
202203 25.455 287.504 29.236
202206 28.318 296.311 31.558
202209 31.933 296.808 35.527
202212 29.970 296.797 33.344
202303 29.012 301.836 31.740
202306 29.645 305.109 32.084
202309 31.100 307.789 33.366
202312 31.092 306.746 33.471
202403 31.198 312.332 32.984
202406 33.282 314.175 34.981
202409 34.274 315.301 35.895
202412 37.533 315.605 39.270
202503 36.687 319.799 37.882
202506 37.875 322.561 38.773
202509 39.502 324.800 40.160
202512 43.409 324.054 44.234
202603 42.896 330.213 42.896

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €107.19 mean?
DaVita (STU:TRL) has a Cyclically Adjusted Revenue per Share of €107.19 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on DaVita and its competitors.
Is DaVita's Cyclically Adjusted Revenue per Share too high?
DaVita's current Cyclically Adjusted Revenue per Share is €107.19. Overall, DaVita has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Cyclically Adjusted Revenue per Share compare to EHC and THC?
DaVita's Cyclically Adjusted Revenue per Share of €107.19 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on DaVita and its competitors. DaVita's current Cyclically Adjusted Revenue per Share is €107.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (STU:TRL) is currently considered Significantly Overvalued. The stock's GF Value™ is €152.35, compared to a current price of €203.00 — trading 33.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €107.19. DaVita's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For DaVita (STU:TRL), the current Cyclically Adjusted Revenue per Share is €107.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (STU:TRL) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of €203.00 is trading 33.2% above its estimated GF Value™ of €152.35. GuruFocus considers DaVita to be Significantly Overvalued.

Key valuation signals for STU:TRL:

  • Cyclically Adjusted Revenue per Share: €107.19
  • GF Value™: €152.35 vs. price of €203.00 (33.2% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the STU:TRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
82GF Score

Get the complete analysis for STU:TRL

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€203.00
Price
€152.35
GF Value